NCT05913895

Brief Summary

Inpatients or outpatients diagnosed with head and neck cancer who met the inclusion and exclusion criteria were referred to the co-investigator(Dr. Chih-Jen Huang and Dr. Hui-Ching Wang), who then personally explained to each participant, the purpose and conduct of the study, so that they all understood their rights and interests before giving a written consent.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable head-and-neck-cancer

Timeline
3mo left

Started Dec 2023

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Dec 2023Oct 2026

First Submitted

Initial submission to the registry

June 4, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 22, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

December 24, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2024

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2026

Expected
Last Updated

December 27, 2023

Status Verified

May 1, 2023

Enrollment Period

5 months

First QC Date

June 4, 2023

Last Update Submit

December 24, 2023

Conditions

Keywords

head and neck cancerhydrogen watercancer related symptom

Outcome Measures

Primary Outcomes (1)

  • Participants With Treatment-Related Adverse Events as Assessed by CTCAE v5.0,Change From Baseline in Pain Scores on the Brief Pain Inventory-Taiwan Scale at 2 Weeks

    weight and height will be combined to report BMI in kg/m\^2

    2 weeks

Study Arms (2)

hydrogen water

EXPERIMENTAL

At the end of cancer treatment (chemotherapy, radiotherapy, or Chemoradiotherapy), a hydrogen water gargle (dissolved for 12 hours or longer) was administered by the investigator or a researcher every Monday through Friday. The changes in six scales described above were tracked in the experimental and control groups on days 1 (T1), 3 (T2), 7 (T3), and 14 (T4) after the end of treatment.

Other: hydrogen water

boiled water

PLACEBO COMPARATOR

At the end of cancer treatment (chemotherapy, radiotherapy, or Chemoradiotherapy),boiled water gargle was administered by the investigator or a researcher every Monday through Friday. The changes in six scales described above were tracked in the experimental and control groups on days 1 (T1), 3 (T2), 7 (T3), and 14 (T4) after the end of treatment.

Other: hydrogen water

Interventions

To investigate whether the intervention of hydrogen water adjuvant therapy can improve oral mucositis, oral frailty, pain and Quality of Life with head and neck cancer who have received radiation therapy or combined chemotherapy.

Also known as: boiled water
boiled waterhydrogen water

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • pathological diagnosed with head and neck cancer
  • adults over the age of 20
  • have normal cognition
  • can use Mandarin or Taiwanese to communicate
  • received radiation therapy or combined chemotherapy

You may not qualify if:

  • Eastern Cooperative Oncology Group (ECOG) performance status 2, 3 and 4
  • received oral cancer surgery within two months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaohsiung Medical University Chung-Ho Memorial Hospital

Kaohsiung City, Sanmin Dist, 807, Taiwan

Location

MeSH Terms

Conditions

Head and Neck NeoplasmsStomatitisPain

Interventions

Water

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsMouth DiseasesStomatognathic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

HydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Study Officials

  • Chih-Jen Huang

    Kaohsiung Medical University Chung-Ho Memorial Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2023

First Posted

June 22, 2023

Study Start

December 24, 2023

Primary Completion

May 19, 2024

Study Completion (Estimated)

October 31, 2026

Last Updated

December 27, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations